Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas W Ball

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Molecular and Cellular Biology|January 2, 2003
The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathwayJong-In Park, Christopher J Strock, Douglas W Ball, et al.
Cytokine|December 23, 2004
Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cellsJong-In Park, Christopher J Strock, Douglas W Ball, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 16, 2007
Unusual case of metastatic neuroendocrine tumorMichele A Manahan, Alan P B Dackiw, Douglas W Ball, et al.
The Journal of Clinical Endocrinology and Metabolism|September 3, 2009
Dual inhibition of mitogen-activated protein kinase kinase and mammalian target of rapamycin in differentiated and anaplastic thyroid cancerNing Jin, Tianyun Jiang, D Marc Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
Synergistic action of a RAF inhibitor and a dual PI3K/mTOR inhibitor in thyroid cancerNing Jin, Tianyun Jiang, David M Rosen, et al.
Virchows Archiv : an International Journal of Pathology|May 7, 2021
Lenvatinib-related renal microangiopathy: a case seriesMarco Delsante, Jose M Monroy-Trujillo, Naima Carter-Monroe, et al.
The Journal of Clinical Endocrinology and Metabolism|September 20, 2007
Selective growth inhibition in BRAF mutant thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244Douglas W Ball, Ning Jin, D Marc Rosen, et al.
Experimental Cell Research|December 2, 2004
GDNF-induced leukemia inhibitory factor can mediate differentiation via the MEK/ERK pathway in pheochromocytoma cells derived from nf1-heterozygous knockout miceJong-In Park, James F Powers, Arthur S Tischler, et al.
Journal of Computer Assisted Tomography|September 19, 2013
Serendipity in the diagnosis of pheochromocytomaAlexander Roman Oshmyansky, Abdelkader Mahammedi, Alan Dackiw, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancerChristopher J Strock, Jong-In Park, D Marc Rosen, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Molecular and Cellular Biology|January 2, 2003
The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathwayJong-In Park, Christopher J Strock, Douglas W Ball, et al.
Cytokine|December 23, 2004
Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cellsJong-In Park, Christopher J Strock, Douglas W Ball, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 16, 2007
Unusual case of metastatic neuroendocrine tumorMichele A Manahan, Alan P B Dackiw, Douglas W Ball, et al.
The Journal of Clinical Endocrinology and Metabolism|September 3, 2009
Dual inhibition of mitogen-activated protein kinase kinase and mammalian target of rapamycin in differentiated and anaplastic thyroid cancerNing Jin, Tianyun Jiang, D Marc Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
Synergistic action of a RAF inhibitor and a dual PI3K/mTOR inhibitor in thyroid cancerNing Jin, Tianyun Jiang, David M Rosen, et al.
Virchows Archiv : an International Journal of Pathology|May 7, 2021
Lenvatinib-related renal microangiopathy: a case seriesMarco Delsante, Jose M Monroy-Trujillo, Naima Carter-Monroe, et al.
The Journal of Clinical Endocrinology and Metabolism|September 20, 2007
Selective growth inhibition in BRAF mutant thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244Douglas W Ball, Ning Jin, D Marc Rosen, et al.
Experimental Cell Research|December 2, 2004
GDNF-induced leukemia inhibitory factor can mediate differentiation via the MEK/ERK pathway in pheochromocytoma cells derived from nf1-heterozygous knockout miceJong-In Park, James F Powers, Arthur S Tischler, et al.
Journal of Computer Assisted Tomography|September 19, 2013
Serendipity in the diagnosis of pheochromocytomaAlexander Roman Oshmyansky, Abdelkader Mahammedi, Alan Dackiw, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancerChristopher J Strock, Jong-In Park, D Marc Rosen, et al.
Pageof 5